Skip to main content

Table 4 Univariable and multivariable analysis for patients after matching

From: Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study

Parameters

Univariable analysis

Multivariable analysis

HR

95% CI

P value

HR

95% CI

P value

Gender Female vs. Male

1.301

0.671–2.524

0.436

   

Age < 60 years vs. ≥ 60 years

0.626

0.317–1.235

0.177

   

Smoking No vs. Yes

0.656

0.255–1.678

0.381

   

Alcoholism No vs. Yes

1.076

0.471–2.456

0.862

   

ASA class II vs. III

0.790

0.360–1.733

0.556

   

Hypertension No vs. Yes

0.689

0.314–1.512

0.353

   

Diabetes mellitus No vs. Yes

0.994

0.414–2.389

0.990

   

CAD No vs. Yes

1.045

0.369–2.954

0.935

   

Hepatitis No vs. Yes

1.199

0.164–8.752

0.858

   

CEA < 5 ng/ml vs. ≥5 ng/ml

1.841

0.958–3.539

0.067

   

CA19–9 <37 U/ml vs. ≥ 37 U/ml

1.302

0.593–2.857

0.510

   

Albumin<40 g/dl vs. ≥ 40 g/dl

1.241

0.643–2.394

0.520

   

HGB <110 g/L vs. ≥ 110 g/L

1.611

0.734–3.536

0.234

   

Occult blood No vs. Yes

1.537

0.778–3.034

0.216

   

Operation time < 3 h vs. ≥ 3 h

1.483

0.751–2.927

0.256

   

Perioperative blood transfusion No vs. Yes

0.855

0.375–1.953

0.711

   

Tumor location Right-sided vs. Left-sided

1.364

0.597–3.113

0.461

   

Defunctioning stoma No vs. Yes

0.049

0.000–16,660.644

0.642

   

Postoperative complication Absent vs. Present

1.504

0.707–3.189

0.289

   

Differentiation Well/Moderate vs. Poor

1.267

0.648–2.476

0.490

   

Signet-ring cell component Absent vs. Present

2.842

0.388–20.785

0.304

   

Mucin No vs. Yes

1.126

0.585–2.167

0.722

   

Mucin component 0% vs.1–70% vs. > 70%

1.643

1.025–2.635

0.039

1.550

0.958–2.507

0.074

PNI Yes vs. No

2.969

1.049–8.400

0.040

2.105

0.713–6.218

0.178

LVI Yes vs. No

2.675

1.218–5.878

0.014

1.687

0.721–3.944

0.228

T stage 1/2 vs. 3/4

5.531

0.758–40.375

0.092

   

N stage 0 vs. 1/2

2.555

1.231–5.300

0.012

2.210

1.035–4.719

0.041

TNM I/II vs. III

2.555

1.231–5.300

0.012

2.210

1.035–4.719

0.041

  1. ASA American Society of Anesthesiologists, CAD coronary artery disease, CEA carcinoembryonic antigen, CA19–9 carbohydrate antigen 19–9, HGB hemoglobin, TNM tumor-lymph node-metastasis, LVI lymphovascular invasion, PNI perineural invasion